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ABSTRACT: Iron-sulfur (Fe-S) proteins contain prosthetic groups consisting of two or more iron atoms
bridged by sulfur ligands, which facilitate multiple functions, including redox activity, enzymatic function,
andmaintenanceofstructuralintegrity.Morethan20proteins areinvolvedinthebiosynthesisofiron-sulfur
clusters in eukaryotes. Defective Fe-S cluster synthesis not only affects activities of many iron-sulfur
enzymes, such as aconitase and succinate dehydrogenase, but also alters the regulation of cellular iron
homeostasis, causing both mitochondrial iron overload and cytosolic iron deficiency. In this work, we review
human Fe-S cluster biogenesis and human diseases that are caused by defective Fe-S cluster biogenesis.
Fe-S cluster biogenesis takes place essentially in every tissue of humans, and products of human disease
genes, including frataxin, GLRX5, ISCU, and ABCB7, have important roles in the process. However, the
human diseases, Friedreich ataxia, glutaredoxin 5-deficient sideroblastic anemia, ISCU myopathy, and
ABCB7 sideroblastic anemia/ataxia syndrome, affect specific tissues, while sparing others. Here we discuss
the phenotypes caused by mutations in these different disease genes, and we compare the underlying
pathophysiology and discuss the possible explanations for tissue-specific pathology in these diseases caused
by defective Fe-S cluster biogenesis.
HUMAN CELLULAR IRON HOMEOSTASIS
Iron is essential for all eukaryotes and most prokaryotes,
where it is used in the synthesis of heme, iron-sulfur (Fe-S),
1
and other cofactors. Fe-S proteins are involved in catalysis,
redoxreactions,respiration,DNAreplication,andtranscription.
Hemes are found in hemoglobin, myoglobin, and cytochromes,
and recent studies have implicated heme proteins in the regula-
tion of circadian rhythmicity (1) and microRNA processing (2).
Iron homeostasis is tightly regulated to avoid iron toxicity or
irondeficiency.Inhumansystemicironmetabolism,ironuptake,
trafficking,export,andutilizationarehighlyregulated,andthose
processes have been reviewed recently (3-5). Here, for back-
ground,webrieflydescribesomeofthemainproteinsinvolvedin
intracellular iron trafficking (Figure 1). Iron-laden transferrin
(Tf) in the mammalian circulation binds to the transferrin
receptor (TfR1) on the plasma membrane, inducing endocytosis
of the Tf-TfR1 complex. In the endosome, iron is released from
Tf upon acidification of the endosome. Upon reduction to the
ferrous form, iron is transported from the endosome to the cyto-
plasm primarily by the iron importer, DMT1. However, there is
also a DMT1-independent endosomal ferrous iron permeable
channel, TRPML1, in late endosomes and lysosomes (6). Muta-
tions in the TRPML1 gene in humans cause mucolipidosis type
IV disease, a syndrome characterized by motor impairment,
mental retardation, retinal degeneration, and iron-deficiency
anemia. Upon its entry into the cytosol, iron can be assembled
into Fe-S clusters for the maturation of cytosolic and nucleic
proteins (7), incorporated into enzymes such as ribonucleotide
reductase(8),orstoredinferritin.Theloadingofironintoferritin
is facilitated by PCBP1 protein, a recently described cytosolic
chaperone that trafficks iron into the storage protein, ferritin (9).
Mitochondria are the major iron-consuming subcellular orga-
nelles in cells. Iron is imported into mitochondria by mitofer-
rin (10) and is subsequently assembled into Fe-S clusters and
heme. Some of the synthesized heme must be exported out of
mitochondrion to the cytosolic/nuclear compartment to provide
heme cofactors to nonmitochondrial proteins such as guanylate
cyclase, but a mitochondrial heme exporter has not yet been
identified.
In mammalian cells, Fe-S clusters are synthesized in both
mitochondriaandthecytosol(11),incontrasttoyeast,inwhichit
is asserted that de novo Fe-S cluster biogenesis occurs solely in
mitochondria (12). Export of an unknown compound from
mitochondria by a transporter known as ABCB7 in mammals,
and as Atm1 in yeast, appears to be needed for some aspect of
cytosolic Fe-S cluster biogenesis (12). Excess iron may be
exported from cytosol by ferroportin on the plasma membrane,
whereas excess cytosolic heme is thought to be exported by the
putative heme transporter,FLVCR (13, 14). Atthe cellular level,
iron homeostasis is regulated by two iron regulatory proteins,
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IRP1 and IRP2 (15, 16). IRP1 senses the iron status via an Fe-S
switch mechanism: by losing its Fe-S cluster, IRP1 is activated
to become an IRE-binding protein, which increases the rate of
cellular iron uptake and decreases the rate of iron sequestration
by stabilizing TfR1 mRNA and repressing ferritin synthesis.
Fe-S cluster biogenesis is therefore important for the IRP1-
mediated regulation of human iron homeostasis.
HUMAN FE-S CLUSTER BIOSYNTHESIS
Much of what is known about eukaryotic Fe-S cluster
biogenesiswas learned from bacterialFe-S proteins,which were
identifiedinitiallyinnitrogen-fixingbacteria,andsubsequentlyin
Escherichia coli and other bacteria (17). More than 20 proteins
involved in Fe-S cluster biosynthesis have been identified in
yeast (12, 18), and both the bacterial and yeast model systems
have revealed much about Fe-S cluster biogenesis. In the cent-
ral mitochondrial Fe-S cluster synthesis machinery of yeast
(Figure 2), the Nfs1-Isd11 complex functions as a cysteine
desulfurase, providing sulfur. Frataxinisthought toprovide iron
bybindingironwithlowaffinitytoanextendedacidicridgeinthe
protein (19). Isu1, its homologue Isu2, Nfu, Isa1, and Isa2 are all
proposed to function as scaffold proteins upon which Fe-S
clusters are transiently assembled. Ferredoxin (Yah1) and ferre-
doxin reductase (Arh1) are redox proteins that are thought to
provideelectronsforlaterstepsofFe-Sclusterassembly(12,18).
A chaperone and cochaperone pair, known as HscA and HscB in
bacteria or Ssq1 and Jac1 in yeast (20), respectively, along with a
glutaredoxin, Grx5, are thought to facilitate the transfer of Fe-S
clusters from scaffolds to target apoproteins (12, 18). Recently,
interaction of a new component, Iba57, with Isa1 and Isa2 was
observed and shown to have a specific role in the maturation of
mitochondrialaconitase-typeandradicalSAMFe-Sproteins(21).
It has been proposed that an Fe-S compound formed in the
yeast mitochondrial matrix is transported to the cytosol via an
export machinery in the mitochondrial inner membrane and
intermembrane space, involving the transporter Atm1, a sulfhy-
dryl oxidase, Erv1, and glutathione (GSH). The exported com-
pound has been proposed to provide the Fe-Sc o r ef o ra s s e m b l y
of Fe-S clusters in cytosol and nuclei. Two cytosolic P-loop
NTPases, Cfd1 and Nbp35, are proposed to act as scaffolds for
cytosolic Fe-S cluster biogenesis. The ATPase proteins, Nar1
andCia1,mayfunctionincytosolicclustertransfer(12,22),anda
newly identified protein, Dre2 (23), may also contribute to cyto-
solic Fe-S cluster biogenesis in yeast (Figure 2, top panel).
Compared to the yeast model system, human Fe-Sc l u s t e r
biogenesis shares many features, but it also differs in several
important ways (7, 24). In the mitochondrial machinery
(Figure2),ISCSisacysteinedesulfurasethatprovidessulfur(25)
in association with ISD11 protein, which may stabilize the
conformation of ISCS (26). Frataxin is a proposed iron donor
(27); ISCU (28, 29) and NFU are scaffold proteins (30), and
ISCA is likely an alternative scaffold (31). GLRX5 may also
function as a scaffold and may facilitate the transfer of Fe-S
clusters to target apoproteins (32). In the export machinery, the
Atm1-like transporter ABCB7 delivers an unknown signal to the
cytosol that perhaps reflects the mitochondrial iron status.
Components of the mammalian cytosolic Fe-Sm a c h i n e r y
include c-ISCS (25), c-ISD11 (26), c-NFU (30), and c-ISCU
(28, 29). Interestingly, the mitochondrial and cytosolic isoforms
of ISCU are generated from a single gene through alternative
splicing, and similarly, the mitochondrial and cytosolic isoforms
ofNFUarealsogeneratedfromasinglegenebyalternativesplic-
ing products. Importantly, the cytosolic isoform of ISCU has
been shown to have a role similar to that of its mitochondrial
counterpartinFe-Sclusterformationinthecytosol(reviewedin
refs 7 and 11). Recently, a new cytosolic component IOP1, the
Nar1 homologue in humans, was observed to be required for
human cytosolic Fe-S cluster biogenesis (33) and to regulate
hypoxia inducible factor (HIF) activity in the hypoxia response
(34). Human Nbp35 forms a complex with its close homologue
human Cfd1 in vivo, suggesting that a heteromeric P-loop
NTPase complex is required for cytosolic Fe-S cluster assembly
andcellularironhomeostasis(35).Aspecificcandidateforthe
role of the iron donor for cytosolic Fe-S cluster biogenesis
remains to be characterized; interestingly, some frataxin has
been detected in the cytosol (36, 37).
Although the human and yeast Fe-S cluster biogenesis path-
ways share many components, the mechanisms by which cyto-
solic and nuclear Fe-S clusters are assembled appear to differ
significantly. In yeast, it has been proposed that the Atm1
transporter provides either an Fe-S cluster ora typeof modified
sufur for use in cytosolic Fe-S cluster assembly. Cytosolic Fe-S
cluster biogenesis in yeast is thought to depend on the mitochon-
drial Fe-S machinery for this vital ingredient, which has not
been molecularly characterized. Moreover, the transcriptional
regulation of the iron regulon in yeast nuclei also depends on
mitochondrial Fe-S cluster biogenesis (38-40). Using a mito-
chondrial substrate, an Fe-S cluster is thought to be assembled
inthecytosolanddeliveredtoacomplexofGrx3,Grx4,andFra2
proteins. The complex of Grx3, Grx4, and Fra2 constitutes a
crucial part of a signaling pathway that regulates expression of
the iron regulon by regulating nucleocytoplasmic translocation
of Aft1, the major factor that regulates transcription of genes of
the yeast iron regulon (38, 40). Although the mechanism is not
FIGURE 1: Subcellular iron trafficking in human cells. Iron is bound
to transferrin Tf in serum, which interacts with TfR1 on the cell
membrane. Formation of the Tf-TfR1 complex induces endocyto-
sis. Upon acidification of the endosome, iron is released and then
exportedintothe cytosol byDMT1orTRPML1.Ironincytosol has
four main fates. It can be used to assemble Fe-S clusters and other
ironproteinsincytosol,undergotransportintomitochondriaviathe
mitochondrial iron importer, mitoferrin, be loaded into ferritin with
the coordination of the PCBP1 chaperone, or be exported by fer-
roportin. Upon its import into mitochondria, iron is used to synthe-
sizeFe-Sclustersandheme.Anunknowncompoundthatrepresents
the mitochondrial iron status and is a product of Fe-S cluster syn-
thesis appears to be exported by ABCB7, which can affect cytosolic
Fe-Sclusterbiogenesis.Hemeisexportedfromthemitochondriaby
an unknown mechanism and is exported out of some cells by a heme
transporter known as FLVCR.Current Topic/Perspective Biochemistry, Vol. 49, No. 24, 2010 4947
known,theGrx3/4-Fra2complexmayacquirea[2Fe-2S]cluster
in iron-replete cells, and this complex may cause Aft1 to multi-
merize and exit the nucleus; on the other hand, Aft1 remains in
the nucleus of iron-depleted cells and increases the level of
transcription of genes of the iron regulon. In contrast, in human
cells, there are cytosolic isoforms of the cysteine desulfurase and
other basic components, and it is thought that Fe-S clusters can
be synthesized de novo in the cytosol. However, problems with
mitochondrial Fe-S cluster biogenesis adversely affect cytosolic
iron status by inducing the cell to remodel the iron status.
Dysfunctional mitochondrial Fe-S cluster biogenesis leads to
mitochondrial iron overload and cytosolic iron deficiency. This
irondeficiencydirectlyimpairscytosolicFe-Sclusterbiogenesis,
even though all protein components of cytosolic Fe-S assembly
machinery are readily available and the cytosolic Fe-S cluster
biogenesis machinery is independent.
FE-S CLUSTER BIOSYNTHESIS AND HUMAN
DISEASES
Inthe pasttwo decades,severaldiseases have been found tobe
able to be attributed to mutations in genes that encode proteins
involved in human Fe-S cluster biogenesis. This subject was
summarized previously (11), but with new progress in the field,
FIGURE 2: Comparison of Fe-S cluster biogenesis pathways in eukaryotes. In yeast mitochondria, Nfs1 and Isd11 form a complex of cysteine
desulfurase,whichprovidessulfurtoscaffoldproteinsforFe-Sclusterassembly.Thepairofferredoxin(Yah1) andferredoxinreductase(Arh1)
perhaps provides reducing equivalents needed for cluster assembly. The yeast frataxin homologue, Yfh1, provides iron. Iron-sulfur clusters are
assembledonscaffolds,andthereareseveralalternativescaffolds,includingIsu1and-2,Nfu,Isa1and-2,andGrx5.Iba57isthoughttofunction
withthe Isa1and -2scaffoldproteins. Facilitated bychaperone (Ssq1) and cochaperone (Jac1) activities, the preassembledFe-Sc l u s t e r so fI s u 1
and -2 are delivered to target apoproteins in mitochondria. The mitochondrial inner membrane transporter Atm1 has been proposed to export
eitherFe-Sclusterorsulfurtothecytosol,withassistancefromErv1intheintermembranespaceofmitochondria,andthiscompound“X”could
thenbeusedtoassembleFe-Sclustersinthecytosolbyscaffoldproteins,includingCfd1,Nbp35,Nar1,andCia1.TheassembledFe-Scl us te rs
are delivered to apoproteins, including the Grx3/4-Fra2 complex, which regulates the nucleocytoplasmic translocation of Aft1 by an unknown
mechanism.Asatranscriptionfactor,Aft1regulatestranscriptionoftheironregulonintheyeastnucleus.Interestingly,thereisafractionofNfs1
proteins present in yeast nucleus (109). In human mitochondria, ISCS and ISD11 form a complex that provides sulfur to scaffold proteins for
Fe-S cluster biogenesis, while FXN is thought to provide iron. Potential scaffold proteins include ISCU, NFU, ISCA1/2, and GLRX5. The
assembledFe-Sclustersaredeliveredtoapoproteinsformaturation.Therolesofhumanferredoxin,ferredoxinreductase,Iba57,chaperone,and
cochaperone homologues in mitochondrial Fe-S cluster biogenesis remain to be confirmed. An unknown molecule that depends on
mitochondrial Fe-S cluster biogenesis for function is exported by ABCB7. We propose that the ABCB7-exported molecule may serve as a
signalthatinducesirontranscriptionalremodelinginthenucleustoappropriatelyregulatemitochondrialironhomeostasisinresponsetoasignal
received from the mitochondria. In the cytosol, the cytosolic forms of ISCS and ISD11, c-ISCS and c-ISD11, respectively, provide sulfur, while
iron can be directly acquired from cytosol, though its exact molecular source is not known. Fe-S clusters are likely synthesized de novo on
c-ISCU,c-NFU,c-ISCA1,orNUBP1(Nbp35)scaffolds.IOP1mayfunctioninthedeliveryoftheclustertoapoproteins.Theinvolvementofthe
human Cfd1 homologue (NUBP2) and Cia1 homologue (Ciao1) in cytosolic Fe-S cluster biogenesis remains to be studied.4948 Biochemistry, Vol. 49, No. 24, 2010 Ye and Rouault
here werevisit the role of compromised Fe-S cluster synthesisin
the pathogenesis of human diseases.
Frataxin and Friedreich’s Ataxia. Frataxin (FXN) is a
mitochondrial iron binding protein involved in Fe-S cluster
biosynthesis. Human frataxin is transcribed into a primary
mRNA 1.3 kb in size (41). Human FXN protein is synthesized
asa210-aminoacidprecursorprotein,butmultiplesmallerinter-
mediate forms are found which do not conform to the sizes
expected after traditional mitochondrial import, cleavage, and
processing. The different sizes of frataxin maturation may arise
from tissue-specific differences in processing (42). Under normal
conditionsinadulttissues,FXNislocalizedtothe mitochondria,
while under oxidative stress, a cytosolic FXN has been observed
which may facilitate the regeneration of Fe-S clusters damaged
by reactive oxygen species (ROS) (43). Various studies suggest
that FXN functions as either an iron chaperone (44), an iron
storageprotein(45),an irondonorforhemebiosynthesis(46),an
iron donor for Fe-S cluster repair, or a regulator of iron
export (44, 47). However, it is widely believed that the main role
ofFXNistosupplyironinabioavailableformformitochondrial
Fe-S cluster synthesis.
Mutations in frataxin cause Friedreich’s ataxia (FRDA), a
recessive neurodegenerative disease that is the most common
form of inherited ataxia in humans. FRDA is a degenerative
disease that involves the central and peripheral nervous systems
and the heart (48), which is characterized by a progressive gait
and limb ataxia, a lack of tendon reflexes in the legs, loss of
position sense, dysarthria, and leg weakness. Neurons in the
dorsal root ganglia are adversely affected, and hypertrophic
cardiomyopathy is found in almost all patients (49). The age of
onset is usually around puberty, and always before age 25. In the
affected tissues, excess iron accumulation is observed in mito-
chondria of cardiac myocytes and neurons (50-52). Molecular
analysis reveals that activities of Fe-S proteins such as aconitase
and succinate dehydrogenase are reduced in FRDA patient cells.
Excess ironisimportedand accumulated inmitochondria, which
leads to irondeficiency inthe cytosol.IRP proteins areactivated,
and cellular iron homeostasis is impaired (53, 54).
Approximately2%ofFRDApatientsarefoundtohave point
mutations in the frataxin gene, whereas 98% of patients have
frataxin genes that contain an unstable GAA trinucleotide
expansion in the first intron (48). Normal alleles contain 6-34
of these GAA repeats, but the expanded alleles of patients
contain 66-1700 repeats. The expansion of the GAA repeat
has been proposed to lead to gene silencing by allowing hetero-
chromatin formation to silence transcription (55) or to inhibit
transcription of the frataxin gene by facilitating formation of a
persistent DNA-RNA hybrid. The age of onset and the severity
ofthe disease areinverselycorrelated with the lengthof the GAA
repeat sequence, and there isevidence that the GAA repeats may
expand as patients age. Therapies for FRDA are aimed at
alleviating transcriptional inhibition and reversing heterochro-
matin formation using histone deacetylase inhibitors (55). Ad-
ditionally,acoenzymeQhomologueantioxidant,idebenone,was
reported to have a positive effect on the cardiomyopathy in most
patients, but it did not have noticeable effects on the ataxia
(56, 57). Other therapies focus on removing excess iron from
mitochondria and redistributing it to the cytosol (58). Thus far,
there has been little success in the treatment of FRDA.
GLRX5 and Sideroblastic Anemia. The glutaredoxins
(Grx) area groupof thioltransferasesthatreducedisulfidebonds
or catalyze reversible protein de- or glutathionylation (59). The
Grx5 genes, including human GLRX5, encode a highly con-
servedmitochondrialmonothiolglutaredoxin.Grx5homologues
in yeast and zebrafish are required for Fe-S cluster biogene-
sis (60, 61), although their precise functions in the process
remain unknown. Recently, two plant chloroplastic monothiol
glutaredoxins were shown to ligate a [2Fe-2S] cluster upon
reconstitution in vitro, leading to the suggestion that Grx5-like
proteins may function as scaffolds (62). In grx5 knockout
zebrafish, the extent of Fe-S cluster assembly is substantially
decreased. By losing its Fe-S cluster, IRP1 of zebrafish is
activatedtoanIRE-binding protein,whichblocksthe expression
of ALAS2, the first enzyme of heme biosynthesis in erythroid
cells, because the ALAS2 transcript contains an iron responsive
element (IRE) in its 50 UTR. The deletion of grx5 in fish results
in severe hypochromic anemia and is embryonically lethal (61).
A complementation experiment has demonstrated that human
GLRX5 is able to rescue Fe-S cluster synthesis in grx5 mutant
yeast,suggestingthatthefunctionofGLRX5hasbeenconserved
during evolution (63).
In humans, the GLRX5 mutation causes microcytic side-
roblastic anemia (SA), as shown by a recently identified male
patient from Italy (64). Sideroblastic anemias are anemias cha-
racterized by the presence of ring sideroblasts, which represent
erythroidprecursor cellsthat containiron-overloaded mitochon-
driathatcongregateinaringaroundthenucleusandaredetected
bythePrussianbluestainforiron.Thepatienthasahomozygous
A294G mutation in the third nucleotide of the last codon of
GLRX5 exon 1. This substitution does not change the encoded
amino acid (glutamine), but it interferes with the correct splicing
andremovalofintron1anddrasticallyreducesgrx5mRNA(64).
Western blotting confirms that the GLRX5 protein is absent in
multipletissuesof the patient, including hematopoietic cells (e.g.,
lymphoblast) and nonhematopoietic cells (e.g., fibroblast) (32).
Likecounterparts inother eukaryotes,human GLRX5 isalso an
Fe-S cluster synthetic protein in mitochondria, which likely
functions as a scaffold protein. The GLRX5 protein deficiency
results in a defect in Fe-S cluster biogenesis in multiple tissues,
but not all tissues develop a pathologic phenotype. Activation
of IRP proteins suppresses the translation of 50 IRE-containing
transcripts (mostly iron-utilizing genes) but promotes the stabi-
lity and translation of 30 IRE-containing transcripts involved in
iron uptake such as TfR1. The imbalance of mitochondrial iron
homeostasis induced by GLRX5 knockdown somehow induces
mitochondrial iron overload. An ultimate consequence is the
accumulation of iron in mitochondria and iron deficiency in the
cytosol (32, 64).
Microarray analysis of fibroblasts from the GLRX5-deficient
patient indicates that there is significant transcriptional remodel-
ing in the patient cells. In particular, the iron exporter gene
ferroportin (FPN1) is significantly upregulated, potentially ex-
acerbating the cytosolic iron deficiency. Although GLRX5
knockdown affects both Fe-S cluster biogenesis and heme syn-
thesis pathways and affectsalmostall tissues,mosttissues donot
manifest significant pathology, perhaps because other proteins
can compensate for the defect of Fe-S cluster biogenesis, and
cellsotherthanerythroidcellsdonotneedtomakelargeamounts
of heme. However, the situation is totally different in erythroid
cells, which express a heme synthetic ALAS2 isoform that con-
tains a 50 IRE and is subject to IRP repression and a specific
FPN1b transcript that does not have a 50 IRE and can therefore
evade repression by IRPs when there is cytosolic iron defici-
ency (65). The GLRX5 knockdown activates IRPs and therebyCurrent Topic/Perspective Biochemistry, Vol. 49, No. 24, 2010 4949
decreases the level of ALAS2 expression and interrupts heme
biosynthesis, but activated IRPs cannot repress FPN1b expres-
sion,whichisinducedduringthestressresponsetomitochondrial
iron overload and worsens cytosolic iron deficiency in eythroid
cells (Figure 3). The combined effect is that the red blood cell
function is highly compromised by a failure to synthesize
sufficient heme and by iron deficiency (32).
In the clinic, the personal history of the unique GLRX5-
deficient patient was unremarkable until age 44, when mild
anemia and type 2 diabetes were diagnosed. Laboratory tests
showed high levels of blood Tf saturation, serum ferritin, biliru-
bin, and liver transaminases. At age 60, the patient manifested
severe sideroblastic anemia, insulin-dependent diabetes, and
cirrhosis. XLSA with ataxia was ruled out by the absence of
neurologic symptoms. Laboratory tests showed increased serum
ferritin,urinaryiron,andliverironconcentrations.Bonemarrow
biopsy showed erythroid hyperplasia and abundant iron. Blood
transfusion made the preexisting iron overload worse. Instead,
iron chelation treatment was started at age 60 with subcutaneous
deferoxamine (Dfo) at 30 mg/kg. Clinical improvement was
noticed within 6 months. Serum ferritin and liver iron levels
were decreased, and hemoglobin levels were increased (64). A
recent rescue experiment of GLRX5 patient fibroblasts using a
lentiviral vector that carries the wild-type GLRX5 gene sequence
demonstrated that restored GLRX5 expression could improve
cell growth, reverse mitochondrial iron overload, and increase
aconitase activity (Figure 4) (32). These results indicate that
gene therapy of the patient’s bone marrow cells could offer a
potential treatment for congenital GLRX5-deficient patients in
the future.
ISCU and Myopathy. ISCU is the major scaffold protein
upon which the transient Fe-S clusters are initially assembled
and from which they are thendelivered to recipient proteins.The
human ISCU gene encodes two forms of protein by alternative
splicing. The 14 kDa protein is mitochondrial (m-ISCU) and the
15 kDa protein cytosolic (c-ISCU), and m-ISCU is much more
abundant (28). In vitro reconstitution assays indicate that both
forms of ISCU protein are active in Fe-S cluster assembly (66).
FIGURE 3: GLRX5deficiencycausesanemiabut doesnot significantlyaffectnon-erythroidtissues.Innormalerythroblasts,ALAS2andFECH
inmitochondriacontributetohemesynthesis,whichisincorporated intohemoglobin(Hb). Erythroblasts aretheonlycellsthatexpress ALAS2,
which contains a IRE in its 50 UTR. All other cells express ALAS1, which is not regulated by the IRE-IRP system. Erythroblasts encode two
formsoftheferroportin(FPN1) transcript,IRE-FPN1aandnon-IRE-FPN1b.BothencodeanidenticalFPN1proteinthatfunctionsastheiron
exporter.Uponerythroiddifferentiation,bothALAS2expressionandFECHexpressionareupregulated,thusincreasingthelevelofsynthesisof
heme and hemoglobin, while FPN1 expression is downregulated (65). In contrast, Fe-S cluster biogenesis is defective in GLRX5-deficient
erythroblasts,ironaccumulatesinmitochondria,andassociatedirondeficiencyincytosolactivatesIRPproteins.ThelevelofALAS2expression
isdecreasedbyIRPrepressionofits50 IRE.ThelevelofFECHexpressionisalsodecreased,mostlikelybecauseFECHdoesnotacquiretheFe-S
cluster it needs for stabilization (69). Together, heme synthesis and subsequent hemoglobinization are inhibited. Levels of expression of both
FPN1 transcripts, including both FPN1a and FPN1b, are increased, perhaps in response to the stress caused by mitochondrial iron overload.
Because FPN1b lacks the IRE, the expression of FPN1b evades the IRP repression and increases the level of expression of FPN1, which may
exacerbate cytosolic iron deficiency. As a result, the GLRX5-deficient erythroblasts fail to produce enough heme for hemoglobinization upon
differentiation.AlthoughGLRX5-deficientnon-erythroblastsalsodemonstrateironoverloadinmitochondriaandcytosolicirondeficiency,they
express ALAS1, which does not have IRE and is not repressed by IRPs. Thus, heme synthesis is not significantly impaired in non-erythroid cell
types. In addition, non-erythroblast cells express only FPN1a, which can be repressed by IRPs as cells develop cytosolic iron depletion.4950 Biochemistry, Vol. 49, No. 24, 2010 Ye and Rouault
Silencing of c-ISCU by siRNA impairs Fe-S cluster assembly in
cytosol, suggesting that c-ISCU is fully functional in vivo (29).
In contrast, silencing ofm-ISCUdecreases Fe-S proteinactivity
in both mitochondria and cytosol, perhaps because it disturbs
mitochondrial and cytosolic iron homeostasis.
A point mutation of ISCU was found to be responsible for
hereditary myopathy with severe exercise intolerance in a group
of Swedish patients described in the past four decades (67, 68).
Nineteen patients from nine families have been identified in
Sweden, and all but one could be connected to a common ances-
tor. These patients have a homozygous intronic G7044C muta-
tionatapotentialacceptorsplicesitebetweenexons4and5ofthe
ISCU gene. The substitution creates a polypyrimidine tract that
promotes spliceosome assembly and leads to the inclusion of an
additional exon, exon 4A, in the transcript. ISCU protein levels
are drastically reduced in patient muscle samples, perhaps
because the mutation introduces a premature stop codon that
destabilizes the protein. The ISCU depletion leads to defective
Fe-S cluster biogenesis and to mitochondrial iron overload in
skeletal muscle. Without sufficient Fe-S cluster biogenesis, the
heme synthetic enzyme ferrochelatase (FECH) is unstable and is
significantly degraded in patient muscle (69). More recently, a
newISCUmutationwas identified intwo malesiblings (70),who
are heterozygous for the intronic G7044C mutation commonly
seen in all other myopathy patients. Additionally, the brothers
have a novel G149A missense mutation in exon 3 that changes a
highly conserved glycine residue to glutamate. ISCU proteins
in these patients are expressed at a normal level, but they are
nonfunctional. The two brothers demonstrate more severe
muscle pathology than other ISCU mutation patients.
Furthermore, in contrast to others, these brothers show the
additionalphenotypeofcardiachypertrophicmyopathy,which
represents a new manifestation for diseases caused by ISCU
mutations.
Clinically,thepatientshavelifelongsevereexercise intolerance
that begins in childhood. Minor exertion causes fatigue of active
muscles, shortness of breath, and cardiac palpitations in associa-
tionwithlacticacidosis(67,68).Patientsalsoexperienceepisodes
of rhabdomyolysis associated with muscle swelling and pain,
weakness, and myoglobinuria. At present, there is no effective
therapy available for ISCU-deficient myopathy, but a potential
strategy is to manipulate gene expression by using antisense
oligonucleotides (71), in which the antisense treatment induces
skipping ofthe pseudoexons inpatientsand results inrestoration
of wild-type mRNA expression.
The Mitochondrial ATP Binding Cassette Protein,
ABCB7, X-Linked Sideroblastic Anemia and Ataxia Syn-
drome (XLSA/A), and a Proposed Connection to Iron-
Sulfur Cluster Biogenesis. ABCB7 proteins, including human
ABCB7, are ABC half-transporters in the mitochondrial inner
membrane (72, 73). As shown in the yeast ABCB7-like homo-
logue, Atm1, the transporter exposes a C-terminal ATP binding
domain to the mitochondrial matrix and spans the membrane
with six transmembrane segments. Atm1 has been proposed to
export an unknown form of iron or Fe-Sc o m p o u n df r o mt h e
mitochondrion to cytosol for the maturation of cytosolic Fe-S
proteins (74-77) and is proposed to be a key component of the
putative Fe-S cluster export machinery. However, an extensive
analysis of ATM3 gene mutant plants has suggested that the
Atm1-like proteins in plants do not export any iron but rather
export one or two compounds required for both Fe-S cluster
and molybdenum cofactor (Moco) assembly in the cytosol (78).
FIGURE 4: Example of mitochondrial iron overload and its reversal when iron-sulfur cluster biogenesis is restored. Shown in the left panels are
severalfibroblaststhatarestainedwiththePerls’DABironstainingtechnique,whichdetectsferricironandenhancesthesignalwithprecipitation
of DAB. Iron overload is present in a reticular pattern consistent with the mitochondrial network of patient fibroblast cells (left), but the iron
depositsdisappearedinpatientcellsrescuedbythewild-typeGLRX5gene(right),introducedeitherbytransfection(top)orbyviraltransduction
(bottom) (32). The scale bars are 10 μm.Current Topic/Perspective Biochemistry, Vol. 49, No. 24, 2010 4951
As a Moco synthesis intermediate, cPMP, accumulated in
mitochondria of ATM3 mutant plants (79), the ATM3 protein
was proposed to be a cPMP transporter. On the basis of the fact
that mutations of SLC25A38, SLC19A2, ABCB7, and heme
synthetic ALAS2 all cause a similar sideroblastic anemia pheno-
type (80) and the prediction that SLC25A38 may provide the
glycine substrate of heme biosynthesis and SLC19A2 may pro-
vide thiamine for pyruvate dehydrogenase, it is possible that
ABCB7 exports a heme or heme precursor molecule to the
cytosol that conveys a signal about mitochondrial iron status
to the cytosolic/nuclear compartment. If levels of this putative
signaling molecule decrease, the cell imports more iron from the
cytosol into mitochondria, resulting in mitochondrial iron over-
load and cytosolic iron deficiency, which slows cytosolic Fe-S
cluster biogenesis. These molecular events could explainthe side-
roblasticandanemicphenotypes.However,sincehumanpatients
with mutations of FECH, which catalyzes the last step in heme
synthesis, do not usually show mitochondrial iron overload, we
hypothesize that the ABCB7 substrate could be a product of an
earlier step in heme synthesis. One such candidate is aminolevu-
linic acid (δ-ALA), the product of condensation of glycine and
succinyl-CoA catalyzed by ALAS2. The mitochondrial carrier
protein SLC25A38 is the putative glycine importer (81). The high-
affinity thiamine transporter SLC19A2 may provide the thiamine
cofactor for pyruvate dehydrogenase which is required for
the production of succinyl-CoA (82). Notably, mutations in
SLC25A38,SLC19A2,andALAS2allcausesideroblasticanemia.
Human ABCB7 has an additional role in heme synthesis and
hematopoiesis as revealed by a putative interaction between
ABCB7 and FECH which has been demonstrated in pull-down
assays, and anemia caused by ABCB7 depletion (83, 84). In con-
trast to non-hematopoietic tissues that do not demonstrate an
observable phenotype, the bone marrow is markedly hypocellu-
lar in ABCB7 knockout mice (84) and the the levels of hemoglo-
bin, absolute reticulocytes, white blood cells, and platelets are
all decreased. Mutations of ABCB7 in humans cause heredi-
taryX-linkedsideroblastic anemiaandataxia(XLSA/A)(73).
The mutated ABCB7 gene is on the X chromosome; in males
(XY), one copy of the mutated gene is sufficient to cause the
disorder, while in females (XX), a mutation must be present in
both copies to cause the condition. Men are therefore affected
more frequently than women. Another well-known XLSA is
caused by mutations in the ALAS2 gene which encodes the first
enzyme of heme synthesis in erythroid cells. Three families of
patients with ABCB7-caused XLSA/A have been studied so far,
and all affected patients are males, consistent with the X-linked
feature. In the first family, the nucleotide T at position 1200 is
mutated to G (T1200G), which changes the amino acid of Ile
(ATT)toMet(ATG)atposition400(I400M)intheprotein.This
residue is within the predicted fifth transmembrane domain of
ABCB7 (85). In the second family, a single missense mutation is
found in exon 10 of the ABCB7 gene in two affected brothers,
and the mutation is a G-to-A transition at nucleotide 1305,
resulting in a Glu-to-Lys substitution at residue 433 (E433K) in
the putative sixth transmembrane domain of ABCB7 (72). In the
third family, the affected brothers have a G-to-C transition at
position 1299, which predicts a V411L substitution in the sixth
putative transmembrane domain (86). All these disease-causing
mutations are in transmembrane segments, indicating the im-
portance of transmembrane segments to ABCB7 function.
In animal models, ABCB7 depletion decreases the rate
of cytosolic Fe-S protein maturation. IRP1 converts to its
IRE-bindingformand inhibits the expression of ALAS2 inheme
synthesis. Cellular iron homeostasis is impaired, and iron accu-
mulates in mitochondria (77). This observation provides a clue
for understanding the human disease. Although the level of
protoporphyrin IX, the substrate of ferrochelatase (FECH), was
found to be slightly increased (1.33-fold) in ABCB7 knockdown
HeLa cells (87), there is no evidence that free protoporphyrin IX
accumulates in ABCB7-deficient human patients and mouse
models (77, 84, 86). Rather, the level of zinc protoporphyrin
was increased in some patients and mouse models (84, 86). The
increaseinthelevelsofzincprotoporphyrinindicatesthatFECH
is functional, but ferrous iron is not available for production of
theironprotoporphyrin,heme(84).Inadditiontoitsimportance
in erythropoiesis, ABCB7 may be required for mitochondrial
ironhomeostasisinneuralcells,assuggestedbyataxiasymptoms
in patients.
ABCB7-caused XLSA/A is characterized by nonprogressive
cerebellar ataxia (with an infantile to early childhood onset) and
mild hypochromic microcytic anemia (85). In some patients, the
level of protoporphyrin IX is increased in erythrocytes despite
normalironstores.Bonemarrowbiopsyconfirmsthepresenceof
ring sideroblasts (86), and some patients show retarded develop-
ment (72). There is no cure for XLSA/A.
Other Genes and Possible Diseases. Human ISCA is likely
an alternative scaffold, since it complements the growth of the
yeast ISA1 mutant, which has been demonstrated to function in
Fe-S cluster assembly in yeast (88). ISCA is present as an auto-
antigen in a patient with Sjogren’s syndrome, an autoimmune
disease(31),buthowandwhyISCAisassociatedwiththedisease
remainunknown. The molecular chaperone/cochaperone (HscA/
HscB) system required for Fe-S cluster assembly in bacteria and
yeast may be in the same pathway as frataxin in Fe-Sc l u s t e r
synthesis, because the phylogenetic distributions of hscA/hscB
and frataxin genes overlap significantly (89). It was further
hypothesized that the mutation of human hscA/hscB may cause
hereditary ataxia syndromes similar to that caused by frataxin
mutations (90), based on the observations that the expression
pattern of human HscA/HscB in mitochondria-rich tissues is
similar to that of frataxin and human HscB and frataxin both
have conserved regions that probably play a role in protein-
proteininteractions(20,91).However,patientswithmutationsin
HscA or -B have not been identified. Finally, because FECH
deficiency causes erythropoietic protoporphyria (EPP), man-
ifesting painful skin photosensitivity due to protoporphyrin
accumulation (92), and deficient Fe-S cluster biogenesis
severely diminishes FECH protein levels (69), there might be
some cases of EPP in human patients caused by deficient Fe-S
cluster assembly.
CONCLUDING REMARKS AND PERSPECTIVES
Spatial Separation of Fe-S Cluster Biogenesis Machin-
ery. In spite of the significant role of mitochondria in cellular
Fe-Sclusterbiogenesis,itisapparentnowthatFe-Sclustersare
assembled separately in distinct subcellular compartments in
mammalian cells (11) and in other organisms. Even in micro-
sporidia,primitiveintracellularparasitesofothereukaryotesthat
have tiny mitochondrial remnants called mitosomes, some essen-
tial components of Fe-S biogenesis are not located in the mito-
some (93). Whereas microsporidial Hsp70 and Nfs1 are located
in mitosomes, the main pools of Isu1 and frataxin are cytosolic.
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full Fe-S synthetic machinery is represented both inside and
outside the mitosomes of microspordia, and Fe-S cluster bio-
genesis can occur independently in both compartments. The
existence of multiple distinct Fe-S assembly systems is well-
recognized in photosynthetic eukaryotes, which contain Fe-S
assembly systems in mitochondria, plastids, and the cytosol
(94-97). To date, it is thought that Fe-S cluster biosynthesis
in plastids is independent of mitochondria. Unlike that in yeast,
theessentialcytosolicFe-SproteinNbp35actswithouttheCfd1
partner in plants (98). Photosynthetic eukaryotes express Cfd1
proteins; one Cfd1 homologue called HCF101 is located in
chloroplasts, whereas the other localizes to mitochondria rather
thanthecytosol(97).ItislikelythatthespatiallyseparatedFe-S
synthetic machinery of the mitochondria and plastids of a single
cell needs to be coordinated and regulated, to optimize cellular
iron homeostasis and compartmental distribution.
Disease Mechanisms. In each of the diseases caused by
defective Fe-S cluster biogenesis, the failure of mitochondrial
Fe-Sclusterbiogenesisleadstodiminishedactivityofmitochon-
drial Fe-S proteins, mitochondrial iron overload, and cytosolic
irondepletion(Figure 5).The cytosolic iron sensors IRP1, which
senses iron levels through an iron-sulfur cluster, and IRP2,
which senses iron levels through iron-dependent degradation by
the hemerythrin-like ubiquitin ligase, FBXL5 (99-101), are
activated, and they repress synthesis of proteins such as ferritin
andferroportin,whichareencodedbytranscriptsthatcontainan
IRP binding site in the 50 UTR and increase the rate of synthesis
of iron uptake proteins such as TfR1. However, these disorders
produce strong tissue specificity; in Friedreich’s ataxia, cardio-
myocytesandasubsetofneurons,especiallysensoryneurons,are
adversely affected, whereas other tissues are spared. In ISCU
myopathy, only skeletal muscles and cardiac cells are affected,
andinglutaredoxin5deficiency,theonlydiseasemanifestationis
anemia (Table 1). Thus, Friedreich ataxia patients have sensory
impairments and heart problems; ISCU myopathy patients are
weak, and the glutaredoxin 5-deficient patient is anemic. The
phenotypes of these diseases differ significantly, even though
eachdiseasegeneadverselyaffectsthefundamentalprocessof
Fe-S cluster biogenesis. Pathology is manifested as sensory
problems in Friedreich’s ataxia, sideroblastic anemia in GLRX5
deficiency, and myopathy in ISCU deficiency, but it is unlikely
that the fundamental defect is limited to these specific tissues, at
leastforsomegenemutations.Forinstance,althoughtheABCB7
missense mutations affect all tissues, the major phenotype is
sideroblastic anemia and ataxia, perhaps suggesting the ABCB7
protein has specific roles in neural and erythroid cells.In the case
of GLRX5 deficiency, although it has been shown that asympto-
matic tissues also lack the GLRX5 protein, the primary pheno-
type is limited to erythroid cells. Recent studies have suggested
that the tissue specificity is due to the special combination of
ALAS2,whichcontainsa50 IRE,andFPN1b,whichlacksa50
IRE (32); these two transcripts are simultaneously expressed
only in erythroid cells, where activation of IRPs would be
expected to cause unique effects.
It has been found that mitochondrial dysfunction leads to
nuclear genome instability and that a reduced level of Fe-S
cluster biogenesis especially in the cytosol (involving NAR1) is
sufficienttoinducegenomeinstability(102).Theseresultssuggest
that Fe-S cluster biogenesis is involved in a form of mitochon-
drion-to-genome communication. Another piece of evidence is
that the cytosolic Fe-S synthetic protein, IOP1 (the NAR1
homologue in humans), was found to regulate the expression of
HIF-1R (34),animportant transcriptionfactor.Weproposethat
mammalian cells use a product of Fe-S cluster biogenesis to
gauge and regulate mitochondrial iron homeostasis, similar to
the role of cytosolic Fe-S cluster biogenesis in the regulation of
the cytosolic regulatory protein, IRP1.
Elusive Mechanism That Links the Failure of Mitochon-
drialFe-SClsuterBiogenesistoMitochondrialIronOver-
load and Cytosolic Iron Deficiency. As noted before in the
human diseases described, and also in tissue culture and knock-
down studies of several Fe-S proteins, including ISCU (29),
frataxin (53), and ISD11 (26), defective mitochondrial Fe-S
cluster assembly appears to trigger a chain of events. First, mito-
chondrial Fe-S proteins, including aconitase and succinate
dehydrogenase, fail to acquire their Fe-S prosthetic groups.
Then there is a change in mitochondrial iron homeostasis that
results in profound mitochondrial iron overload. Thismitochon-
drial iron overload likely results from an increased level of iron
import by the dedicated iron transporter, mitoferrin, and also
from a diminished level of export by uncharacterized mitochon-
drial iron exporters. It is likely that mitochondrial iron overload
contributessignificantlytodiseaseprogressionbyoxidatively
damaging the mitochondria, which further impairs function.
FIGURE 5: Deficiency in mitochondrial Fe-S cluster biogenesis
causesmitochondrialironoverload,relativecytosolicirondeficiency,
and activation of the cytosolic iron sensor proteins, IRP1 and IRP2.
Deficiency in many of the major proteins involved in mitochondrial
Fe-S cluster biogenesis results in defective mitochondrial Fe-S
clusterbiogenesis,whichinturnresultsintranscriptionalremodeling,
mitochondrial iron overload, and cytosolic iron deficiency. IRP
proteinsareactivatedtobeRNAregulatoryproteins,whichincrease
the rate oftranslation of 30 IRE-mRNA, such asTfR1, whereas they
inhibit the translation of mRNAs that contain IREs in the 50 UTR,
such as ferritin and ferroportin.
Table 1: Primarily Affected Tissues in Fe-S Cluster Synthesis Diseases
a
FXN GLRX5 ISCU ABCB7
erythroblasts þþ
sensory and cerebellar neurons þþ
cardiomyocytes þþ
skeletal myocytes þ
aThe primarily affected cell types are sensory neurons and cardiac
myocytes for frataxin-deficient Friedreich’s ataxia, erythroblasts and cer-
ebellar neurons for ABCB7-deficient XLSA/A, skeletal and cardiac myo-
cytesforISCU-deficientmyopathy,anderythroblastsforGLRX5-deficient
sideroblastic anemia.Current Topic/Perspective Biochemistry, Vol. 49, No. 24, 2010 4953
Since mitochondrial iron overload appears to be caused by a
failure of Fe-S cluster biogenesis and to contribute significantly
to disease, it is increasingly important to understand the mole-
cular events that contribute to mitochondrial iron overload. In
the yeast model system, it was initially postulated that iron
overload occurred because mitochondria lacked a dedicated iron
exporter,andironcouldexitthemitochondriamainlyintheform
of fully formed Fe-S clusters that would load clusters onto
cytosolic and nuclear apoproteins. The loss of function of the
yeast counterpart of ABCB7, Atm1, resulted in a loss of activity
of the cytosolic Fe-S protein, Leu1 (103, 104), and this informa-
tion was interpreted to mean that Atm1 exported Fe-S clusters
forinsertionintocytosolicFe-S proteins such as Leu1p and that
its homologue ABCB7 exported Fe-Sc l u s t e r sf o ru s ei nt h e
cytosol of higher eukaryotes.
However,thenotionthatthemitochondriawerethesolesiteof
Fe-S cluster biogenesis in eukaryotes was undermined by the
discoverythatisoformsofthecysteinedesulfurase,ISCS,thescaf-
fold, ISCU, and the alternative scaffold, NFU, not only were
present in the cytosol but also were shown to be important for
cytosolicFe-Sclusterbiogenesisinmammaliancells(29).Justas
mammalian cytosolic iron homeostasis is regulated in part by a
cytosolic iron-sulfur protein, IRP1, which functions either as a
cytosolic aconitase or as an RNA regulatory protein depending
on iron status, it is very likely that mitochondrial iron home-
ostasisisalsohighlyregulated.Perhapsaniron-sulfurproteinor
a product of an iron-sulfur protein is exported from mitochon-
dria and programs transcription of genes involved in mitochon-
drial iron uptake and export to increase or decrease the level of
mitochondrial iron in response to this proposed exported signal-
ing molecule. When synthesis of this mitochondrial iron status
signaling molecule is defective, the cell responds to misperceived
mitochondrial iron depletion by increasing the rate of mitochon-
drial iron uptake and decreasing the rate of export. Indeed, the
level oftranscriptionalexpression ofthe mitochondrial importer,
mitoferrin, is increased in a Friedreich’s ataxia model (54).
Moreover, in a yeast model of frataxin deficiency, iron is
mobilizedfromtheironoverloadedmitochondriawithinminutes
after normal frataxin expression is restored (105).
Thephenomenonofmitochondrialironoverloadisnotlimited
to defects iniron-sulfurclusterbiogenesis;italso occursinother
diseases, such as the sideroblastic anemia caused by ALAS2
mutations, even though ALAS2 mediates the first condensation
of heme biosynthesis and is not directly involved in Fe-S cluster
biogenesis. It is also interesting that in fibroblasts and lympho-
blasts frompatientswithFriedreich’s ataxia(53)a n dg l u t a r e d o x -
in 5 deficiency (32), impaired mitochondrial iron-sulfur cluster
biogenesisisaccompaniedbycytosolicirondepletion,whichmay
resultinpartfrom the factthatmitochondrial iron uptakeoccurs
at the expense of cytosolic iron. However, recently another con-
tributing factor has also been identified, because it appears that
mitochondrial iron overload causes oxidative stress which leads
to activation of genes that combat oxidative stress, including
expression of the iron exporter ferroportin (32). The fact that
cytosolicirondepletionoccursinconjunctionwithmitochondrial
iron overload may explain why cytosolic iron-sulfur proteins
have been known to be deficient in function. With insufficient
ironfor de novo cytosolic iron-sulfur cluster synthesis, activities
ofiron-sulfurproteinsdecrease,withsignificantimplicationsfor
activities of known cytosolic iron-sulfur proteins such as IRP1
(15), the DNA repair enzymes XPD and FancJ (106), and PRI2,
which is involved in DNA replication (107). Interestingly, array
studies in yeast have revealed that interruption of mitochondrial
iron-sulfur cluster biogenesis results in remodeling of iron
metabolism, and loss of frataxin and loss of Atm1 both result
in a markedly reduced level of transcription of Leu1 (108), the
cytosolic iron-sulfur protein that was originally the basis for the
hypothesisthatmitochondriawerethesolesourceofiron-sulfur
clusters. Clearly, if the level of transcription of Leu1 is dimin-
ished, expression of the protein and enzymatic activity will be
decreased,whichwasobserved,thoughthislossofLeu1pactivity
was attributed previously to weakened acquisition of the iron-
sulfur prosthetic group by the intact and abundant apoprotein.
On the basis of the problems with iron-sulfur cluster biogen-
esis in three human diseases, and the problems that are engen-
dered in mitochondrial and cytosolic iron homeostasis, we
suggest that the next frontier will consist of molecular char-
acterization of a molecule synthesized in mitochondria that is
exported to the cytosolic/nuclear compartment, perhaps by
ABCB7, and which represents a gauge of mitochondrial iron
status by possessing or depending on an iron-sulfur cluster for
function. Regulation of mitochondrial iron homeostasis likely
dependsonmitochondrialsignalingandtranscriptionalremodel-
ing, and elucidation of the molecular details of this regulatory
pathway may reveal important insights into an emerging class of
human diseases.
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